Ainos Inc (AIMD) - Total Liabilities

Latest as of June 2026: $16.28 Million USD

Based on the latest financial reports, Ainos Inc (AIMD) has total liabilities worth $16.28 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Ainos Inc's assets to evaluate the company's liquid asset resilience ratio.

Ainos Inc - Total Liabilities Trend (1995–2025)

This chart illustrates how Ainos Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Ainos Inc's balance sheet.

Ainos Inc Competitors by Total Liabilities

The table below lists competitors of Ainos Inc ranked by their total liabilities.

Company Country Total Liabilities
GlycoMimetics Inc
NASDAQ:GLYC
USA $2.62 Billion
KINGFISH COMPANY EO -01
F:93G
Germany €122.14 Million
Dharma Samudera Fishing Tbk
JK:DSFI
Indonesia Rp153.62 Billion
TDH Holdings Inc
NASDAQ:PETZ
USA $9.57 Million
Ostin Technology Group Co Ltd
NASDAQ:OST
USA $45.60 Million
Victrex plc
LSE:VCT
UK GBX135.70 Million
Inventure Growth & Securities Limited
NSE:INVENTURE
India Rs-2.76 Billion
Globe Kita Terang Tbk PT
JK:GLOB
Indonesia Rp1.10 Trillion

Liability Composition Analysis (1995–2025)

This chart breaks down Ainos Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Ainos Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.96 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.83 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ainos Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ainos Inc (1995–2025)

The table below shows the annual total liabilities of Ainos Inc from 1995 to 2025.

Year Total Liabilities Change
2025-12-31 $13.31 Million +0.03%
2024-12-31 $13.30 Million +79.92%
2023-12-31 $7.39 Million +198.03%
2022-12-31 $2.48 Million -91.90%
2021-12-31 $30.63 Million +2687.72%
2020-12-31 $1.10 Million +45.83%
2019-12-31 $753.31K +2.68%
2018-12-31 $733.62K -59.76%
2017-12-31 $1.82 Million +43.26%
2016-12-31 $1.27 Million +115.97%
2015-12-31 $589.24K +30.28%
2014-12-31 $452.28K -90.85%
2013-12-31 $4.94 Million +16.55%
2012-12-31 $4.24 Million +0.57%
2011-12-31 $4.22 Million +16.23%
2010-12-31 $3.63 Million -27.21%
2009-12-31 $4.99 Million +58.90%
2008-12-31 $3.14 Million +12.84%
2007-12-31 $2.78 Million +0.98%
2006-12-31 $2.75 Million +4.10%
2005-12-31 $2.65 Million -6.62%
2004-12-31 $2.83 Million +5.08%
2003-12-31 $2.70 Million -18.63%
2002-12-31 $3.31 Million +2.88%
2001-12-31 $3.22 Million +5.32%
2000-12-31 $3.06 Million +89.98%
1999-12-31 $1.61 Million -44.83%
1998-12-31 $2.92 Million +3.69%
1997-12-31 $2.81 Million +1.34%
1996-12-31 $2.78 Million -13.22%
1995-12-31 $3.20 Million --

About Ainos Inc

NASDAQ:AIMD USA Scientific & Technical Instruments
Market Cap
$10.12 Million
Market Cap Rank
#27129 Global
#5618 in USA
Share Price
$1.37
Change (1 day)
-4.86%
52-Week Range
$1.29 - $4.25
All Time High
$156.75
About

Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing indus… Read more